News for Crescent Capital BDC, Inc. (CCAP)

LOS ANGELES, April 22, 2025 (GLOBE NEWSWIRE) -- Crescent Capital BDC, Inc. (”œCrescent BDC”) ( CCAP) today announced it will release its financial results

Crescent Capital experienced a stock price drop of over 10% due to uncertainty about its income potential and value proposition. Read why CCAP is a Buy.

Crescent Capital BDC, Inc. offers a 10.6% dividend yield, trades at 11% discount to book value, delivering solid returns with stable NAV. Read why I rate CCAP as a Strong Buy.

Investors need to pay close attention to Crescent Capital BDC (CCAP) stock based on the movements in the options market lately.

Crescent Capital BDC (CCAP) reports Q4 2024 earnings with declining NII and NAV amid rising risks.

Crescent Capital BDC, Inc. (NASDAQ:CCAP) Q4 2024 Earnings Conference Call February 20, 2025 ETCompany ParticipantsDan McMahon - Head, IRJason Breaux -...

Crescent Capital BDC (CCAP) delivered earnings and revenue surprises of -1.79% and 1.30%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Crescent Capital BDC declares $0.42 quarterly dividend, 8.4% yield. Special $0.15 cash dividends announced for 2025 in three installments.

**media[545028]**

Crescent Capital BDC Inc (CCAP) is set to release its Q4 2024 earnings on Feb 19, 2025. The consensus estimate for Q4 2024 revenue is $47.27 million, and the ea

Main Street Capital, Barings BDC and Crescent Capital BDC are part of the Zacks Industry Outlook article.

Crescent Capital BDC (CCAP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Crescent Capital BDC focuses on originating and investing in the debt of private middle-market companies, aiming for income and capital appreciation. Read about the company's baby bonds.

**media[532246]**

Crescent Capital BDC (CCAP) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Crescent Capital BDC (CCAP) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Crescent Capital BDC boasts an 8.6% yield and low non-accruals. Learn why CCAP stock offers a reliable income stream with strong dividend sustainability.

CCAP is a defensive BDC with a 90% concentration on first-lien debt, ensuring high repayment priority during potential litigation processes. Read more here.

Crescent Capital stock is a business development pick delivering steady dividend income as well as capital appreciation.